9 Soi Ramindra 19 Yeak 1, Anusawaree, Bangkhen Bangkok 10220 Thailand

Mon – Fri: 8 AM – 5 PM / Sat – Sun: Closed

Atlanta Medicare Company Limited

About Us

History of Atlanta Medicare

Atlanta Medicare Company Limited was founded in 2007.

Mr. Suphadej Amnuaysakul established a pharmaceutical business in Bangkok, Thailand, with commercial leadership in HIV.

Atlanta medicare Company Limited aspire to be the most recognized in sales & marketing and also distribution in pharmaceutical business in Thailand. We are committed to sourcing
the best quality of pharmaceutical medicines, vaccines, medical devices and consumer healthcare products from worldwide by enabling people to have a new chance in medical treatment and have a better health and better life. 

Strategy

  • Staying close to the Thai Key Opinion Leaders and bring to them what they need
  • Locate the Right Principals who have Innovative & Value Added Products for Thailand
  • Register Products with our Learned Quality In-house Regulatory team
  • Organize Quantum of Innovative Activities to Build Long Term Brands for our Principals
  • Invest in our delighting High Service Functional Teams to bring the Best out of them

Company Overview

  • Headquartered in Bangkok, Thailand
  • Incorporated in 2007
  • Started operations in January 2008
  • A Marketing & Distribution company
  • 23 Bangkok Sales Representatives
  • 43 Up-country Sales Representatives

Achievements

  • First Generic Tenofovir in the Country in HIV and Hep B
  • First TDF/FTC and TDF/FTC/EFV in the country
  • First to launch BRCAnalaysis from Myriad
  • Fist to launch a 25 Gene Panel Test – myRisk
  • Breast Cancer Molecular Expression Test similarly for Prostate
  • First to launch Suplasyn 1-Shot
  • First to launch PVDF range of Meshes for Hernia, Pelvic Repair and Stress/Urge Incontinence
  • Successfully doing four CMEs each year since 2010
  • Lot of firsts are in the Pipeline
  • First to launch Tenofovir Alafenamide for Chronic Hepatitis B
  • First to launch Sorafenib for Liver Cancer
  • First to launch Dolutegravir for HIV
  • First to launch Dolutegravir, Tenofovir Disoproxil Fumarate and Lamivudine
  • First to launch Dolutegravir, Tenofovir Alafinamide  and Emtricitabine
  • First to launch Cidofovir for CMV (Cytomegalovirus)
2009
2010
2011
2012
2013
2015
2019
2021
2022
2023
2024
2025
Launched Tenofovir (TEE regimen) from Mylan and started CME programs
Pioneered Dolutegravir as Thailand's first generic HIV treatment
Expanded into medical devices market with Dynamic support products
Launched HIV Antiviral Drugs from Matrix Labs
Introduced TLD regimen to elevate HIV care to global standard
Partnered with Micro Labs for general medicine (Diabetes & Hypertension)
Added Naprod as oncology partner – imported Vesimycin (Mitomycin)
Imported medical supplies from Germany and Cancer Test Kits from the US

Imported Hernia and Incontinence Mesh from Dynamesh (Germany)
Distributed Glenmark’s Dermatology and Respiratory Medicines
Partnered with Natco – launched First Generic TAF (Hepatitis B)
Launched TLD from Mylan and Dipromed’s surgical devices (Italy)
Partnered with Kusum and Incepta – Rheumatoid Arthritis Medicines
Launched First Generic Sorafenib / Partnered with Softgel (soft Gelatin)
Added Macleods as Tuberculosis Medicine Partner
Expanded into Antibiotics (Qliu), Peptides (Hybio), Biologics (Lupin)